ERD

Periodic Reporting for period 2 - ENDFLU (Evaluation of ratioNally Designed Influenza vaccines)

Project: ENDFLU

Updated at: 31-08-2024

Show more information

Project acronym ENDFLU

Cellular immunological assay package

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Humoral immunological assay package

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antib...

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Inf...

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Biophysical Correlates of Enhanced Immunogenicity of a Stabilized Variant of the Receptor Binding Domain of SARS-CoV-2.

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Chapter 2 - Deep mutational scanning to probe specificity determinants in proteins

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Computational design of vaccine immunogens

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Mosaic N1 and N2 neuraminidase nanoparticles induce high antibody titers and potent protection from Influenza A virus H1...

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin S...

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

The identification of novel promoters and terminators for protein expression and metabolic engineering applications in K...

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Influenza vaccines: successes and continuing challenges

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Composition of the SAB

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

ENDFLU website

Project: ENDFLU

Updated at: 31-10-2023

Show more information

Project acronym ENDFLU

Resources

Selected filters:

Periodic Reporting for period 2 - ENDFLU (Evaluation of ratioNally Designed Influenza vaccines)

Cellular immunological assay package

Humoral immunological assay package

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antib...

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Inf...

Biophysical Correlates of Enhanced Immunogenicity of a Stabilized Variant of the Receptor Binding Domain of SARS-CoV-2.

Chapter 2 - Deep mutational scanning to probe specificity determinants in proteins

Computational design of vaccine immunogens

Mosaic N1 and N2 neuraminidase nanoparticles induce high antibody titers and potent protection from Influenza A virus H1...

Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin S...

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression

The identification of novel promoters and terminators for protein expression and metabolic engineering applications in K...

Influenza vaccines: successes and continuing challenges

Composition of the SAB

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

ENDFLU website